AQUESTIVE THERAPEUTICS INC (AQST) Stock Income Statement
NASDAQ:AQST - Nasdaq - US03843E1047 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 54.23M | 57.56M | 50.58M | 47.68M | 50.83M | |||
| Cost Of Goods | 17.14M | 17.87M | 20.83M | 19.39M | 14.99M | |||
| Gross Profit | 37.09M | 39.69M | 29.75M | 28.29M | 35.84M | |||
| Operating Expenses | 78.27M | 70.46M | 44.85M | 70.36M | 70.52M | |||
| Research and Development | 19.71M | 20.28M | 13.10M | 17.48M | 17.05M | |||
| Selling, General, and Administrative Expenses | 58.56M | 50.18M | 31.75M | 52.88M | 53.48M | |||
| Operating Income | -41.18M | -30.77M | -15.10M | -42.07M | -34.68M | |||
| Interest Income/Expense | -7.30M | -7.68M | 9.98M | -12.34M | -22.04M | |||
| Other Income/Expense | -5.78M | -5.70M | -1.13M | N/A | N/A | |||
| Non Recurring Items | N/A | 0.00 | -1.38M | 0.00 | -13.82M | |||
| Income Before Taxes | -54.25M | -44.15M | -7.63M | -54.41M | -70.54M | |||
| Income Tax | -14.00K | -14.00K | 245.00K | 0.00 | 0.00 | |||
| Net Income | -54.24M | -44.14M | -7.87M | -54.41M | -70.54M | |||
| EBITDA | -40.53M | -30.05M | -13.76M | -39.68M | -31.72M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.58 | -0.51 | -0.13 | -1.12 | -1.85 | |||
| Non GAAP EPS | -0.59 | -0.52 | -0.36 | -1.14 | -1.49 | |||
| Statistics | ||||||||
| Gross Profit Margin | 68.40% | 68.95% | 58.82% | 59.33% | 70.51% | |||
| Profit Margin | -100.02% | -76.68% | -15.56% | -114.11% | -138.78% | |||
| Operating Profit Margin | -75.94% | -53.46% | -29.86% | -88.23% | -68.23% | |||
All data in USD